Patents Represented by Attorney Clark & Elbing LLP
  • Patent number: 8101366
    Abstract: Methods of selecting patients with sepsis for treatment with an anti-inflammatory and/or anticoagulatory agent are provided.
    Type: Grant
    Filed: December 19, 2007
    Date of Patent: January 24, 2012
    Assignee: AntibodyShop A/S
    Inventors: Kristian Bangert, Lars Otto Uttenthal
  • Patent number: 8101177
    Abstract: Anti-VEGF antibodies and variants thereof, including those having high affinity for binding to VEGF, are disclosed. Also provided are methods of using phage display technology with naive libraries to generate and select the anti-VEGF antibodies with desired binding and other biological activities. Further contemplated are uses of the antibodies in research, diagnostic and therapeutic applications.
    Type: Grant
    Filed: July 27, 2010
    Date of Patent: January 24, 2012
    Assignee: Genentech, Inc.
    Inventors: Germaine Fuh, Hans-Peter Gerber, Wei-Ching Liang, Frederic A. Fellouse, Sachdev S. Sidhu, Christian Wiesmann
  • Patent number: 8102176
    Abstract: This invention relates generally to detection devices having one or more small wells each surrounded by, or in close proximity to, an NMR micro coil, each well containing a liquid sample with magnetic nanoparticles that self-assemble or disperse in the presence of a target analyte, thereby altering the measured NMR properties of the liquid sample. The device may be used, for example, as a portable unit for point of care diagnosis and/or field use, or the device may be implanted for continuous or intermittent monitoring of one or more biological species of interest in a patient.
    Type: Grant
    Filed: September 2, 2008
    Date of Patent: January 24, 2012
    Assignee: T2 Biosystems, Inc.
    Inventor: W. David Lee
  • Patent number: 8097648
    Abstract: The invention provides methods and compositions for use in treating diseases associated with excessive cellular proliferation, such as cancer.
    Type: Grant
    Filed: November 18, 2005
    Date of Patent: January 17, 2012
    Assignee: Eisai R&D Management Co., Ltd.
    Inventors: Bruce A. Littlefield, Murray J. Towle, Boris M. Seletsky, Melvin J. Yu, Wanjun Zheng
  • Patent number: 8093410
    Abstract: Methods of synthesizing intermediates useful for the synthesis of halichondrin B analogs are described.
    Type: Grant
    Filed: October 3, 2008
    Date of Patent: January 10, 2012
    Assignee: Eisai R&D Management Co., Ltd.
    Inventors: Charles Chase, Atsushi Endo, Frances G. Fang, Jing Li
  • Patent number: 8092797
    Abstract: Anti-VEGF antibodies and variants thereof, including those having high affinity for binding to VEGF, are disclosed. Also provided are methods of using phage display technology with naïve libraries to generate and select the anti-VEGF antibodies with desired binding and other biological activities. Further contemplated are uses of the antibodies in research, diagnostic and therapeutic applications.
    Type: Grant
    Filed: February 4, 2010
    Date of Patent: January 10, 2012
    Assignee: Genentech, Inc.
    Inventors: Germaine Fuh, Hans-Peter Gerber, Wei-Ching Liang, Frederic A. Fellouse, Sachdev S. Sidhu, Christian Wiesmann
  • Patent number: 8088567
    Abstract: The present invention relates to an immortalized human neural precursor cell line, NGC-407. The cell line has been established from human foetal tissue. The cell line has been immortalized using a retroviral vector containing the v-myc oncogene. The cell line is a neural progenitor cell line capable of differentiating into to astrocytes and neurons including dopaminergic neurons. NGC-407 cells are capable of migrating to glioblastoma tumours implanted into rat brains and form gap junctions with the tumour cells. NGC-407 cells expressing a suicide gene can be be used for delivering activated prodrugs in the form of activated nucleoside analogs to tumours.
    Type: Grant
    Filed: March 30, 2006
    Date of Patent: January 3, 2012
    Assignee: NsGene A/S
    Inventor: Bengt Juliusson
  • Patent number: 8088740
    Abstract: The present invention relates to gold binding peptides and shape- and size-tunable synthesis of gold nanostructures. The present inventions are very useful for the production of well-designed, gold-based architectures. The size- and shape-specific gold nanostructure materials prepared by the present invention may find use as: highly conductive interconnections for single-electron transistors, catalysts for the oxidation of carbon monoxide; biological and chemical sensors; and as contrasting agents for electron microscopic and medical imaging applications.
    Type: Grant
    Filed: May 4, 2009
    Date of Patent: January 3, 2012
    Assignee: Gwangju Institute of Science and Technology
    Inventors: Hor Gil Hur, Jung Ok Kim, Dae Hee Kim, No Sang Myung
  • Patent number: 8088391
    Abstract: The invention provides chimeric flavivirus vaccines against West Nile virus and methods of using these vaccines to prevent or treat West Nile virus infection.
    Type: Grant
    Filed: March 23, 2009
    Date of Patent: January 3, 2012
    Assignee: Sanofi Pasteur Biologics Co.
    Inventors: Juan Arroyo, Charles Miller, John Avram Catalan, Thomas P. Monath
  • Patent number: 8084020
    Abstract: The invention provides methods for the administration of an anti-CD 1 antibody for the treatment or prevention of a variety of disorders, such as autoimmune disease, viral infection, bacterial infection, parasitic infection, infection by a eukaryotic pathogen, allergy, asthma, inflammatory condition, graft versus host disease, graft rejection, immunodeficiency disease, spontaneous abortion, pregnancy, and cancer.
    Type: Grant
    Filed: May 1, 2003
    Date of Patent: December 27, 2011
    Assignee: Beth Israel Deaconess Medical Center
    Inventors: Mark A. Exley, Steven P. Balk, Simon C. Yue
  • Patent number: 8080525
    Abstract: Novel peptide compositions are described. In particular, peptide compositions are described which include at least two peptides which are selected from among the following peptides: a peptide A having at least the amino acid sequence of SEQ ID NO 1, a peptide B having at least the amino acid sequence of SEQ ID NO 45, a peptide C having at least the amino acid sequence of SEQ ID NO 127, and a peptide D having at least the amino acid sequence of SEQ ID NO 174. The compositions can be used, in particular, in the preparation of active pharmaceutical compositions against the hepatitis C virus.
    Type: Grant
    Filed: June 3, 2008
    Date of Patent: December 20, 2011
    Assignees: Transgene SA, INSERM (Institut National de la Sante et de la Recherche Medicale)
    Inventors: Anne Fournillier, Nourredine Himoudi, Genevieve Inchauspe
  • Patent number: 8080692
    Abstract: The invention relates generally to the production of oxygenated hydrocarbons such as lower alcohols and more preferably 1,2-propanediol. More particularly, this invention comprises a single-step catalytic process for the catalytic production of lower alcohols such as methanol, ethanol, ethylene glycol and 1,2-propanediol from glycerol in aqueous medium. The catalyst comprises a metal selected from the Group VIII transition metals, preferably platinum, alloys thereof and mixtures thereof and a microporous carrier, preferably a faujasite-type zeolite.
    Type: Grant
    Filed: December 27, 2007
    Date of Patent: December 20, 2011
    Assignee: Katholieke Universiteit Leuven
    Inventors: Els D'Hondt, Pierre Jacobs, Bert Sels
  • Patent number: 8080555
    Abstract: Compounds useful in the treatment of autoimmune disease are described by the following general formula: n=0-2 m=0-2 m is not necessarily equal to n; where R1, R3?NH2, F, Cl, C1-C4 alkoxy or phenoxy group, but R1 is not necessarily equal to R3; and R2?H, F, Cl, NH2, or NH—R—XH;
    Type: Grant
    Filed: May 15, 2006
    Date of Patent: December 20, 2011
    Assignee: Prometic Biosciences Inc.
    Inventors: Boulos Zacharie, Daniel Fortin, Nicole Wilb, Christopher Penney
  • Patent number: 8080553
    Abstract: The invention features a method for treating a patient diagnosed with, or at risk of developing, an immunoinflammatory disorder by administering to the patient a tetra-substituted pyrimidopyrimidine, either alone or in combination with one or more additional agents. The invention also features a composition containing a tetra-substituted pyrimidopyrimidine in combination with one or more additional agents.
    Type: Grant
    Filed: September 7, 2006
    Date of Patent: December 20, 2011
    Assignee: Zalicus Inc.
    Inventors: Curtis Keith, Alexis Borisy, Grant R. Zimmermann, Edward Roydon Jost-Price, Palaniyandi Manivasakam, Nicole Hurst, Michael A. Foley, Michael S. Slavonic, Brendan Smith, Benjamin A. Auspitz
  • Patent number: 8078279
    Abstract: An implantable medical device is configured so that all of the major components including a housing and attached leads are disposed within the vasculature of a patient. A tether extends from the housing of the device to an implant location where the tether is secured to tissue outside of the vasculature. In this manner, an intravascular medical device may be implanted at a location remote from final placement, delivered via the vasculature and anchored at the initial entry point.
    Type: Grant
    Filed: November 19, 2009
    Date of Patent: December 13, 2011
    Inventors: Charles L. Dennis, George J. Klein, Ursula Gebhardt, Kenneth M. Anderson, Glenn C. Zillmer
  • Patent number: 8078253
    Abstract: Provided are methods for diagnosing the presence, type, or severity of a dementia in a human subject. The methods involve using a computer-based system to assess impairment of certain cognitive and motor functions that are indicative of Alzheimer's disease and other forms of dementia.
    Type: Grant
    Filed: February 20, 2003
    Date of Patent: December 13, 2011
    Assignee: The McLean Hospital Corporation
    Inventors: Martin H. Teicher, Steven B. Lowen
  • Patent number: 8076119
    Abstract: The invention relates to a new bacterial strain belonging to the genus Brevibacillus laterosporus deposited at the NCIMB Ltd. Aberdeen, UK and to its derivatives. The bacterium and its derivatives have insecticidal activity and constitute the active principle of compositions and feeding baits used for biological control of Dipters, Nematocers and Brachycerus (flies, mosquitos, horseflies and midges) and especially against the species Musca domestica. Therefore, according to a further aspect, the invention relates to a method for biological control of insects belonging to the order Dipters. The active principle has activity against Nematocers and Brachycerus (flies, mosquitos, horseflies and midges) and especially against the species Musca domestica.
    Type: Grant
    Filed: September 14, 2007
    Date of Patent: December 13, 2011
    Assignee: Universita Degli Studi di Sassari
    Inventors: Ignazio Floris, Luca Ruiu, Alberto Satta, Gavino Delrio, Salvatore Rubino, Bianca Paglietti, David John Ellar, Roberto A. Pantaleoni
  • Patent number: 8076310
    Abstract: Disclosed herein are novel phosphonate nucleosides and thiophosphonate nucleosides comprising a phosphonalkoxy-substituted or phosphonothioalkyl-substituted five-membered, saturated or unsaturated, oxygen-containing or sulfur-containing ring coupled to a heterocyclic nucleobase such as a pyrimidine or purine base. The invention further relates to compounds having HIV (Human Immunodeficiency Virus) replication inhibiting properties and to compounds having antiviral activities with respect to other viruses. The invention also relates to methods for preparation of all such compounds and pharmaceutical compositions comprising them. The invention further relates to the use of said compounds as a medicine and in the manufacture of a medicament useful for the treatment of subjects suffering from HIV infection, as well as for treatment of other viral, retroviral or lentiviral infections and to the treatment of animals suffering from FIV, viral, retroviral or lentiviral infections.
    Type: Grant
    Filed: March 4, 2005
    Date of Patent: December 13, 2011
    Assignee: K.U.Leuven Research & Development
    Inventors: Piet Herdewijn, Christophe Pannecouque, Tongfei Wu, Erik De Clerq
  • Patent number: 8071683
    Abstract: The invention relates to surface modifying macromolecules (SMMs) having high degradation temperatures and their use in the manufacture of articles made from base polymers which require high temperature processing. The surface modifier is admixed with the base polymer to impart alcohol and water repellency properties.
    Type: Grant
    Filed: December 14, 2007
    Date of Patent: December 6, 2011
    Assignee: Interface Biologics Inc.
    Inventors: Sanjoy Mullick, Richard Witmeyer, Paul Santerre, Weilun Chang
  • Patent number: 8070705
    Abstract: A protective sleeve for a body extremity, such as an arm or a leg. The sleeve includes a spacer textile formed into a self-supporting tube for protecting the extremity from pressure, friction, shear, skin tears and bruising. The tube can have a wide end and a narrow end. The extremity slides through the wide end of the tube and the narrow tube end then slides over the foot or hand. Because these tubes are self-supporting, the sleeve can remain coextensive with the extremity while maintaining a loose fit, even during vigorous exercise. The spacer textile provides for both pressure relief and moisture transmission from the skin.
    Type: Grant
    Filed: June 21, 2005
    Date of Patent: December 6, 2011
    Assignee: HipSaver, Incorporated
    Inventor: Edward L. Goodwin